{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:07:57Z","timestamp":1791068877550,"version":"4.1.0"},"reference-count":66,"publisher":"Rockefeller University Press","issue":"6","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":526,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T00:00:00Z","timestamp":1541289600000},"content-version":"vor","delay-in-days":207,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26893051"],"award-info":[{"award-number":["26893051"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["B 15H04855"],"award-info":[{"award-number":["B 15H04855"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-1-0041"],"award-info":[{"award-number":["W81XWH-12-1-0041"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taub Foundation"},{"DOI":"10.13039\/100009784","name":"Starr Foundation","doi-asserted-by":"publisher","award":["I8-A8-075"],"award-info":[{"award-number":["I8-A8-075"]}],"id":[{"id":"10.13039\/100009784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009784","name":"Starr Foundation","doi-asserted-by":"publisher","award":["I9-A9-059"],"award-info":[{"award-number":["I9-A9-059"]}],"id":[{"id":"10.13039\/100009784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017102","name":"Friends of Leukemia Research Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011313","name":"Tokyo Biochemical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,4]]},"abstract":"<jats:p>Additional sex combs like 1 (ASXL1) is frequently mutated in myeloid malignancies and clonal hematopoiesis of indeterminate potential (CHIP). Although loss of ASXL1 promotes hematopoietic transformation, there is growing evidence that ASXL1 mutations might confer an alteration of function. In this study, we identify that physiological expression of a C-terminal truncated Asxl1 mutant in vivo using conditional knock-in (KI) results in myeloid skewing, age-dependent anemia, thrombocytosis, and morphological dysplasia. Although expression of mutant Asxl1 altered the functions of hematopoietic stem cells (HSCs), it maintained their survival in competitive transplantation assays and increased susceptibility to leukemic transformation by co-occurring RUNX1 mutation or viral insertional mutagenesis. KI mice displayed substantial reductions in H3K4me3 and H2AK119Ub without significant reductions in H3K27me3, distinct from the effects of Asxl1 loss. Chromatin immunoprecipitation followed by next-generation sequencing analysis demonstrated opposing effects of wild-type and mutant Asxl1 on H3K4me3. These findings reveal that ASXL1 mutations confer HSCs with an altered epigenome and increase susceptibility for leukemic transformation, presenting a novel model for CHIP.<\/jats:p>","DOI":"10.1084\/jem.20171151","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T07:00:30Z","timestamp":1523430030000},"page":"1729-1747","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":148,"title":["Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation"],"prefix":"10.1084","volume":"215","author":[{"given":"Reina","family":"Nagase","sequence":"first","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"},{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3621-4807","authenticated-orcid":true,"given":"Alessandro","family":"Pastore","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujino","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-An","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimasa","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Goyama","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Saika","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Sera","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Asada","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihito Cojin","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan 4"},{"name":"Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women\u2019s Medical University, Tokyo, Japan 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-1767","authenticated-orcid":true,"given":"Toshio","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"2023072821441957100_bib1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell."},{"key":"2023072821441957100_bib2","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20131141","article-title":"Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo","volume":"210","author":"Abdel-Wahab","year":"2013","journal-title":"J. Exp. Med."},{"key":"2023072821441957100_bib3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physiolgenomics.00028.2004","article-title":"Erythroid-induced commitment of K562 cells results in clusters of differentially expressed genes enriched for specific transcription regulatory elements","volume":"19","author":"Addya","year":"2004","journal-title":"Physiol. Genomics."},{"key":"2023072821441957100_bib4","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1038\/ncomms8307","article-title":"Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex","volume":"6","author":"Balasubramani","year":"2015","journal-title":"Nat. Commun."},{"key":"2023072821441957100_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20160927","article-title":"RUNX1 cooperates with FLT3-ITD to induce leukemia","volume":"214","author":"Behrens","year":"2017","journal-title":"J. Exp. Med."},{"key":"2023072821441957100_bib6","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2023072821441957100_bib7","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1182\/blood-2014-12-618090","article-title":"TGF-\u03b2 signaling in the control of hematopoietic stem cells","volume":"125","author":"Blank","year":"2015","journal-title":"Blood."},{"key":"2023072821441957100_bib8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1182\/blood-2016-01-693119","article-title":"CBF\u03b2-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice","volume":"128","author":"Cai","year":"2016","journal-title":"Blood."},{"key":"2023072821441957100_bib9","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1182\/blood-2010-04-282350","article-title":"Sox6 enhances erythroid differentiation in human erythroid progenitors","volume":"117","author":"Cant\u00f9","year":"2011","journal-title":"Blood."},{"key":"2023072821441957100_bib10","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1073\/pnas.0909296106","article-title":"Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072821441957100_bib11","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1038\/bcj.2013.74","article-title":"Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome","volume":"4","author":"Chen","year":"2014","journal-title":"Blood Cancer J."},{"key":"2023072821441957100_bib12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10555-012-9405-5","article-title":"Animal models of leukemia: any closer to the real thing?","volume":"32","author":"Cook","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"2023072821441957100_bib13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/immu.200310005","article-title":"Transgenic mice with hematopoietic and lymphoid specific expression of Cre","volume":"33","author":"de Boer","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"2023072821441957100_bib14","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1074\/jbc.273.14.8278","article-title":"Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells","volume":"273","author":"Deed","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2023072821441957100_bib15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/emboj.2012.357","article-title":"TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS","volume":"32","author":"Deplus","year":"2013","journal-title":"EMBO J."},{"key":"2023072821441957100_bib16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science."},{"key":"2023072821441957100_bib17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood."},{"key":"2023072821441957100_bib18","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2023072821441957100_bib19","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1172\/JCI68557","article-title":"Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells","volume":"123","author":"Goyama","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2023072821441957100_bib20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia."},{"key":"2023072821441957100_bib21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jcp.21769","article-title":"Molecular pathways mediating MDS\/AML with focus on AML1\/RUNX1 point mutations","volume":"220","author":"Harada","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"2023072821441957100_bib22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1182\/blood-2005-12-5014","article-title":"c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells","volume":"108","author":"Hess","year":"2006","journal-title":"Blood."},{"key":"2023072821441957100_bib23","doi-asserted-by":"publisher","first-page":"29454","DOI":"10.1038\/srep29454","article-title":"Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency","volume":"6","author":"Ikeda","year":"2016","journal-title":"Sci. Rep."},{"key":"2023072821441957100_bib24","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1172\/JCI70739","article-title":"Myelodysplastic syndromes are induced by histone methylation\u2013altering ASXL1 mutations","volume":"123","author":"Inoue","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2023072821441957100_bib25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/leu.2014.301","article-title":"SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS","volume":"29","author":"Inoue","year":"2015","journal-title":"Leukemia."},{"key":"2023072821441957100_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exphem.2015.11.011","article-title":"Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels","volume":"44","author":"Inoue","year":"2016","journal-title":"Exp. Hematol."},{"key":"2023072821441957100_bib27","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0083-3","article-title":"A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies","author":"Inoue","year":"2018","journal-title":"Leukemia"},{"key":"2023072821441957100_bib28","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2023072821441957100_bib29","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","article-title":"The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion","volume":"107","author":"Kamminga","year":"2006","journal-title":"Blood."},{"key":"2023072821441957100_bib30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1247\/csf.07035","article-title":"The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies","volume":"33","author":"Kimura","year":"2008","journal-title":"Cell Struct. Funct."},{"key":"2023072821441957100_bib31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell."},{"key":"2023072821441957100_bib32","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1182\/blood-2012-09-456079","article-title":"Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis","volume":"121","author":"Liu","year":"2013","journal-title":"Blood."},{"key":"2023072821441957100_bib33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cyto.a.22093","article-title":"Flow cytometry analysis of murine hematopoietic stem cells","volume":"83","author":"Mayle","year":"2013","journal-title":"Cytometry A."},{"key":"2023072821441957100_bib34","doi-asserted-by":"publisher","first-page":"15429","DOI":"10.1038\/ncomms15429","article-title":"ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia","volume":"8","author":"Micol","year":"2017","journal-title":"Nat. Commun."},{"key":"2023072821441957100_bib35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s004380050018","article-title":"The Additional sex combs gene of Drosophila is required for activation and repression of homeotic loci, and interacts specifically with Polycomb and super sex combs","volume":"261","author":"Milne","year":"1999","journal-title":"Mol. Gen. Genet."},{"key":"2023072821441957100_bib36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.3150","article-title":"Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis","volume":"19","author":"Murphy","year":"2013","journal-title":"Nat. Med."},{"key":"2023072821441957100_bib37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2009.01.014","article-title":"Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells","volume":"30","author":"Ng","year":"2009","journal-title":"Immunity."},{"key":"2023072821441957100_bib38","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood."},{"key":"2023072821441957100_bib39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3324\/haematol.2014.114157","article-title":"ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group","volume":"100","author":"Paschka","year":"2015","journal-title":"Haematologica."},{"key":"2023072821441957100_bib40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nm.3524","article-title":"Targeting a new regulator of erythropoiesis to alleviate anemia","volume":"20","author":"Paulson","year":"2014","journal-title":"Nat. Med."},{"key":"2023072821441957100_bib41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.stem.2015.05.003","article-title":"Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions","volume":"17","author":"Pietras","year":"2015","journal-title":"Cell Stem Cell."},{"key":"2023072821441957100_bib42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat. Genet."},{"key":"2023072821441957100_bib43","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1038\/sj.onc.1210185","article-title":"TLX1\/HOX11-induced hematopoietic differentiation blockade","volume":"26","author":"Riz","year":"2007","journal-title":"Oncogene."},{"key":"2023072821441957100_bib44","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/bioinformatics\/bts319","article-title":"A common ancestry for BAP1 and Uch37 regulators","volume":"28","author":"Sanchez-Pulido","year":"2012","journal-title":"Bioinformatics."},{"key":"2023072821441957100_bib45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature."},{"key":"2023072821441957100_bib46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/nar\/29.2.397","article-title":"The transcriptional program of a human B cell line in response to Myc","volume":"29","author":"Schuhmacher","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"2023072821441957100_bib47","doi-asserted-by":"publisher","first-page":"28789","DOI":"10.1038\/srep28789","article-title":"ASXL1 plays an important role in erythropoiesis","volume":"6","author":"Shi","year":"2016","journal-title":"Sci. Rep."},{"key":"2023072821441957100_bib48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1101\/gad.268425.115","article-title":"Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a","volume":"30","author":"Shields","year":"2016","journal-title":"Genes Dev."},{"key":"2023072821441957100_bib49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cell.2009.04.042","article-title":"Defining the human deubiquitinating enzyme interaction landscape","volume":"138","author":"Sowa","year":"2009","journal-title":"Cell."},{"key":"2023072821441957100_bib50","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1128\/MCB.01572-08","article-title":"Differential contribution of the Gata1 gene hematopoietic enhancer to erythroid differentiation","volume":"29","author":"Suzuki","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2023072821441957100_bib51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/gtc.12086","article-title":"GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation","volume":"18","author":"Suzuki","year":"2013","journal-title":"Genes Cells."},{"key":"2023072821441957100_bib52","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1200\/JCO.2010.33.4938","article-title":"Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes","volume":"29","author":"Thol","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"2023072821441957100_bib53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molcel.2007.05.030","article-title":"E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases","volume":"27","author":"Tyagi","year":"2007","journal-title":"Mol. Cell."},{"key":"2023072821441957100_bib54","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.1073\/pnas.1600070113","article-title":"Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression","volume":"113","author":"Ueda","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072821441957100_bib55","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood."},{"key":"2023072821441957100_bib56","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1182\/blood-2013-05-500272","article-title":"Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice","volume":"123","author":"Wang","year":"2014","journal-title":"Blood."},{"key":"2023072821441957100_bib57","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood."},{"key":"2023072821441957100_bib58","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nm.3936","article-title":"Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia","volume":"21","author":"Will","year":"2015","journal-title":"Nat. Med."},{"key":"2023072821441957100_bib59","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1128\/JVI.77.8.4965-4971.2003","article-title":"A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms","volume":"77","author":"Wolff","year":"2003","journal-title":"J. Virol."},{"key":"2023072821441957100_bib60","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"2023072821441957100_bib61","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/onc.2009.475","article-title":"Identification of Zfp521\/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia","volume":"29","author":"Yamasaki","year":"2010","journal-title":"Oncogene."},{"key":"2023072821441957100_bib62","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1182\/blood-2007-05-091637","article-title":"Runx1 is involved in primitive erythropoiesis in the mouse","volume":"111","author":"Yokomizo","year":"2008","journal-title":"Blood."},{"key":"2023072821441957100_bib63","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Yokoyama","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2023072821441957100_bib64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature."},{"key":"2023072821441957100_bib65","doi-asserted-by":"publisher","first-page":"e0154480","DOI":"10.1371\/journal.pone.0154480","article-title":"Combined Id1 and Id3 Deletion Leads to Severe Erythropoietic Disturbances","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS One."},{"key":"2023072821441957100_bib66","doi-asserted-by":"publisher","first-page":"17532","DOI":"10.1074\/jbc.M112.439729","article-title":"Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1)","volume":"288","author":"Zhou","year":"2013","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/215\/6\/1729\/1759912\/jem_20171151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/215\/6\/1729\/1759912\/jem_20171151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T17:46:26Z","timestamp":1690566386000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/215\/6\/1729\/42387\/Expression-of-mutant-Asxl1-perturbs-hematopoiesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,4]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20171151","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]}}}